Journal Article

Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound

Lyne Labrecque, Sylvie Lamy, Amélie Chapus, Samira Mihoubi, Yves Durocher, Brian Cass, Michel W. Bojanowski, Denis Gingras and Richard Béliveau

in Carcinogenesis

Volume 26, issue 4, pages 821-826
Published in print April 2005 | ISSN: 0143-3334
Published online April 2005 | e-ISSN: 1460-2180 | DOI:
Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


The vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptors play essential and complementary roles in angiogenesis and combined inhibition of these receptors has been shown to result in potent antitumor activity in vivo. In this study, we report that ellagic acid (EA), a natural polyphenol found in fruits and nuts, inhibits VEGF-induced phosphorylation of VEGFR-2 in endothelial cell (EC) as well as PDGF-induced phosphorylation of PDGFR in smooth muscle cells, leading to the inhibition of downstream signaling triggered by these receptors. EA also specifically inhibited VEGF-induced migration of ECs as well as their differentiation into capillary-like tubular structures and abolished PDGF-dependent smooth muscle cell migration. Interestingly, EA presents a greater selectivity for normal cells than for tumor cells since the migration of the U87 and HT1080 cell lines were much less affected by this molecule. The identification of EA as a naturally occurring dual inhibitor of VEGF and PDGF receptors suggests that this molecule possesses important antiangiogenic properties that may be helpful for the prevention and treatment of cancer.

Keywords: BAEC, bovine aortic endothelial cell; EA, ellagic acid; EC, endothelial cell; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; HUVEC, human umbilical vein endothelial cell; PASMC, pulmonary aortic smooth muscle cell; PDGF, platelet-derived growth factor; PDGFR, platelet-derived growth factor receptor; S1P, sphingosine-1 phosphate; VEGF, vascular endothelial growth factor; VEGFR-2, vascular endothelial growth factor receptor-2; vSMC, vascular smooth muscle cells

Journal Article.  4769 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.